What is AnimalScan?
AnimalScan operates as a premier provider of MRI and CT imaging services, bridging the gap between complex diagnostic requirements and veterinary clinical practice. The company offers a comprehensive suite of solutions, including state-of-the-art imaging hardware, teleradiology expertise, and flexible equipment leasing models. By focusing on high-acuity conditions such as neurological tumors and spinal pathologies, AnimalScan provides essential diagnostic clarity that empowers veterinarians to deliver superior patient outcomes. Their market position is defined by a unique combination of technical proficiency and accessibility, making advanced veterinary diagnostics a standard rather than a luxury in modern pet care.
How much funding has AnimalScan raised?
AnimalScan has raised a total of $341K across 2 funding rounds:
Debt
$150K
Debt
$191K
Debt (2020): $150K with participation from PPP
Debt (2021): $191K led by PPP
Key Investors in AnimalScan
PPP
Public-Private Partnership
What's next for AnimalScan?
With the recent influx of capital, AnimalScan is poised to accelerate its strategic expansion, likely focusing on the integration of artificial intelligence within its teleradiology workflows and the further penetration of the North American veterinary market. The company's focus on late-stage growth suggests a shift toward operational optimization and the potential for broader service diversification. As the demand for specialized pet healthcare continues to climb, AnimalScan's ability to maintain its diagnostic edge will be central to its long-term value proposition. Future initiatives will likely prioritize the scaling of its leasing programs and the enhancement of its collaborative network with veterinary specialists to ensure sustained market leadership.
See full AnimalScan company page